Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HF forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
MINNEAPOLIS, May 10, 2022 Nuwellis, Inc. announced today its results for the first quarter ended March 31, 2022, which included the following highlights: Generated $1.9 million in total. | May 10, 2022